RSV Diagnostics Market by End User (Clinical Laboratories,Hospitals & Clinics, Homecare), by Product (Instruments, Kits and Assays), by Method (Rapid Antigen Detection Test, Molecular Diagnostic) – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: April 1, 2020
Clear
SKU: GMS-1271 Category:

The market for RSV diagnostics is projected to reach USD 1,108 million by 2024, continuing to grow over the forecast period at a CAGR of 9.23%. Market growth is driven primarily by the rising burden of RSV infections, increased demand for PoC molecular diagnostic tests for RSV infection diagnosis, and increased approval of RSV diagnostic kits and assays.

RSV Diagnostics Market by End User (Clinical Laboratories,Hospitals & Clinics,  Homecare), by Product (Instruments, Kits and Assays), by Method (Rapid Antigen Detection Test, Molecular Diagnostic) - 2019 to 2024 1

RSV Diagnostics Market by End User (Clinical Laboratories,Hospitals & Clinics,  Homecare), by Product (Instruments, Kits and Assays), by Method (Rapid Antigen Detection Test, Molecular Diagnostic) - 2019 to 2024 2

RSV Diagnostics Market by End User (Clinical Laboratories,Hospitals & Clinics,  Homecare), by Product (Instruments, Kits and Assays), by Method (Rapid Antigen Detection Test, Molecular Diagnostic) - 2019 to 2024 3

RSV Diagnostics Market by End User (Clinical Laboratories,Hospitals & Clinics,  Homecare), by Product (Instruments, Kits and Assays), by Method (Rapid Antigen Detection Test, Molecular Diagnostic) - 2019 to 2024 4

RSV Diagnostics Market by End User (Clinical Laboratories,Hospitals & Clinics,  Homecare), by Product (Instruments, Kits and Assays), by Method (Rapid Antigen Detection Test, Molecular Diagnostic) - 2019 to 2024 5

RSV Diagnostics Market by End User (Clinical Laboratories,Hospitals & Clinics,  Homecare), by Product (Instruments, Kits and Assays), by Method (Rapid Antigen Detection Test, Molecular Diagnostic) - 2019 to 2024 6

RSV Diagnostics Market by End User (Clinical Laboratories,Hospitals & Clinics,  Homecare), by Product (Instruments, Kits and Assays), by Method (Rapid Antigen Detection Test, Molecular Diagnostic) - 2019 to 2024 7

RSV Diagnostics Market by End User (Clinical Laboratories,Hospitals & Clinics,  Homecare), by Product (Instruments, Kits and Assays), by Method (Rapid Antigen Detection Test, Molecular Diagnostic) - 2019 to 2024 8
RSV Diagnostics Market by End User (Clinical Laboratories,Hospitals & Clinics,  Homecare), by Product (Instruments, Kits and Assays), by Method (Rapid Antigen Detection Test, Molecular Diagnostic) - 2019 to 2024 7

1 Global RSV Diagnostics Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global RSV Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global RSV Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global RSV Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global RSV Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global RSV Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global RSV Diagnostics Market – By Product (Market Size – & million/billion)
8.1 Kits and Assays
8.2 Instruments
8.3 Other Products
8.4 RSV Diagnostics Market, By Methods
8.5 Molecular Diagnostics
8.6 Rapid Antigen Detection Tests
8.7 Other

9 Global RSV Diagnostics Market – By Method
9.1 Molecular Diagnostics
9.2 Rapid Antigen Detection Tests
9.3 Other

10 Global RSV Diagnostics Market – By End-User
10.1 Hospitals and Clinics
10.2 Clinical Laboratories
10.3 Home Care

11 Global RSV Diagnostics Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global RSV Diagnostics Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global RSV Diagnostics Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Biomérieux
13.3 Becton, Dickinson and Company (BD)
13.4 Thermo Fisher
13.5 Abbott
13.6 Roche
13.7 Hologic
13.8 Fast Track Diagnostics
13.9 Danaher
13.10 Biocartis
13.11 Luminex
13.12 Company 11 & more

14 Global RSV Diagnostics Market – Appendix
14.1 Sources
14.2 Abbreviations